Yang Lü

7.2k total citations
171 papers, 4.5k citations indexed

About

Yang Lü is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yang Lü has authored 171 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 51 papers in Oncology and 46 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yang Lü's work include Cancer, Hypoxia, and Metabolism (22 papers), Prostate Cancer Treatment and Research (14 papers) and Sarcoidosis and Beryllium Toxicity Research (12 papers). Yang Lü is often cited by papers focused on Cancer, Hypoxia, and Metabolism (22 papers), Prostate Cancer Treatment and Research (14 papers) and Sarcoidosis and Beryllium Toxicity Research (12 papers). Yang Lü collaborates with scholars based in United States, China and United Kingdom. Yang Lü's co-authors include Zhen Fan, John Mendelsohn, Ke Liang, Bolin Liu, Xinqun Li, Songbo Qiu, Weidong Jin, Gordon B. Mills, Mathias Schmidt and Zhihong Fan and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Yang Lü

160 papers receiving 4.4k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Yang Lü 1.9k 1.9k 971 906 723 171 4.5k
Nina J. Karlin 1.4k 0.7× 2.2k 1.2× 969 1.0× 1.1k 1.2× 555 0.8× 47 4.1k
Antonio Jimeno 2.3k 1.2× 3.1k 1.6× 1.4k 1.5× 921 1.0× 475 0.7× 128 5.2k
Jing Gao 1.7k 0.9× 1.9k 1.0× 1.4k 1.4× 1.1k 1.2× 430 0.6× 240 4.6k
Zhen Fan 2.5k 1.3× 3.0k 1.6× 1.4k 1.5× 1.0k 1.1× 845 1.2× 70 5.6k
Ferry A.L.M. Eskens 2.6k 1.3× 2.9k 1.5× 1.5k 1.5× 1.2k 1.4× 518 0.7× 161 6.4k
Petr Kavan 1.0k 0.5× 1.5k 0.8× 1.1k 1.2× 876 1.0× 417 0.6× 141 4.4k
Tong Zhang 1.5k 0.8× 1.8k 1.0× 2.1k 2.2× 1.1k 1.3× 510 0.7× 162 4.5k
Teresa A. Goldin 2.1k 1.1× 1.9k 1.0× 1.2k 1.2× 1.3k 1.4× 268 0.4× 5 4.7k
Paul Frankel 1.8k 0.9× 1.9k 1.0× 967 1.0× 658 0.7× 404 0.6× 214 4.1k
Kimihiro Shimizu 1.7k 0.9× 1.6k 0.9× 2.1k 2.2× 674 0.7× 650 0.9× 256 4.8k

Countries citing papers authored by Yang Lü

Since Specialization
Citations

This map shows the geographic impact of Yang Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Lü more than expected).

Fields of papers citing papers by Yang Lü

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yang Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Lü. The network helps show where Yang Lü may publish in the future.

Co-authorship network of co-authors of Yang Lü

This figure shows the co-authorship network connecting the top 25 collaborators of Yang Lü. A scholar is included among the top collaborators of Yang Lü based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yang Lü. Yang Lü is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lan, Xin, Shuwen Zhang, & Yang Lü. (2025). Taurine up-regulated 1: A dual regulator in immune cell-mediated pathogenesis of human diseases. Progress in Biophysics and Molecular Biology. 197. 84–96.
2.
Shan, Hu, Yang Lü, Md Ali Mujtaba, et al.. (2025). Oroxylin A exerts antiproliferative effects through downregulation of E6 and E7 oncogenes in cervical cancer HeLa cells. Naunyn-Schmiedeberg s Archives of Pharmacology. 399(3). 3519–3532.
3.
Liu, Zhaoqian, Xi Deng, Yihan Wang, et al.. (2025). Spectral Computed Tomography Diagnosis of Inflammatory Bowel Disease with Neodymium-Hyaluronic Acid Nanoparticles. Biomaterials Research. 30. 301–301.
5.
Hao, Jiarui, et al.. (2024). Increased m6A modification of BDNF mRNA via FTO promotes neuronal apoptosis following aluminum-induced oxidative stress. Environmental Pollution. 349. 123848–123848. 6 indexed citations
6.
Yang, Cuiping, Yang Lü, Jianbin Wang, et al.. (2023). Design and application of artificial rare L-lysine codons in Corynebacterium glutamicum. Frontiers in Bioengineering and Biotechnology. 11. 1194511–1194511. 6 indexed citations
7.
Lü, Yang, Dongfeng Tan, Kathryn Bollin, et al.. (2023). Sclerosing mesenteritis following immune checkpoint inhibitor therapy. Journal of Cancer Research and Clinical Oncology. 149(11). 9221–9227. 4 indexed citations
8.
Lü, Yang, et al.. (2022). [PAHs exposure and its association with oxidative stress and neurotransmitter levels in coal miners].. PubMed. 40(10). 727–732. 1 indexed citations
9.
Dai, Dong, et al.. (2018). Imaging Characteristics of a Bladder Wall Paraganglioma. Clinical Nuclear Medicine. 44(1). 66–67. 9 indexed citations
10.
Mittal, Nupur, Bing Zhu, Sujata Gaitonde, Yang Lü, & Mary Lou Schmidt. (2015). A unique description of stage IV extranodal marginal zone lymphoma (EMZL) in an adolescent associated with gamma heavy chain disease. Pediatric Blood & Cancer. 62(5). 905–908. 2 indexed citations
11.
Ai, Midan, Songbo Qiu, Yang Lü, & Zhen Fan. (2013). HER2 regulates Brk/PTK6 stability via upregulating calpastatin, an inhibitor of calpain. Cellular Signalling. 25(9). 1754–1761. 14 indexed citations
12.
Ai, Midan, Ke Liang, Yang Lü, Songbo Qiu, & Zhen Fan. (2013). Brk/PTK6 cooperates with HER2 and Src in regulating breast cancer cell survival and epithelial-to-mesenchymal transition. Cancer Biology & Therapy. 14(3). 237–245. 29 indexed citations
13.
Li, Li, Yang Lü, Min Li, et al.. (2013). Repeat Percutaneous Vertebroplasty for Recurrent Pain Arising From Previously Treated Vertebrae in Patients With Osteoporotic Vertebral Compression Fractures. Clinical Spine Surgery A Spine Publication. 29(9). 399–404. 5 indexed citations
14.
Sun, Gang, Min Li, & Yang Lü. (2010). Unrecognized lithopedion with 35 years' evolution diagnosed on computed tomographic scan. Fertility and Sterility. 94(1). 341–342. 4 indexed citations
15.
Zhu, Jun, Caigang Liu, Ruishan Zhang, et al.. (2009). Relationship between nestin expression and other clinicopathological factors in breast cancer.. 4(11). 622–625. 1 indexed citations
16.
Lü, Yang. (2009). Clinical observation on the routine and Compound Danshen Dropping Pills in the treatment of patients with acute myocardial infarction. China Medical Herald. 1 indexed citations
17.
Lü, Yang, Xinqun Li, Ke Liang, et al.. (2007). Epidermal growth factor receptor (EGFR) ubiquitination as a mechanism of acquired resistance to the anti-EGFR monoclonal antibody cetuximab. Cancer Research. 67. 4082–4082. 3 indexed citations
18.
Adams, Kristen E., Ke Shi, Sunkuk Kwon, et al.. (2006). Influence of NIR and red fluorescent wavelengths on animal imaging and biological effects of targeting molecules on cancer cells. Clinical Cancer Research. 12. 1 indexed citations
19.
Lü, Yang. (2004). Study of microsatellite instability in hereditary nonpolyposis colorectal cancer. 2 indexed citations
20.
Liang, Ke, Yang Lü, Weidong Jin, et al.. (2003). Sensitization of breast cancer cells to radiation by trastuzumab.. PubMed. 2(11). 1113–20. 201 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026